First-Line Chemotherapy versus Immunotherapy versus Maintenance Therapy
A recent study compared mesothelioma patients’ survival by physician’s choice of treatment. Is first-line chemotherapy the best choice? Malignant pleural…
Immunotherapeutic and Targeted Approaches to Mesothelioma Treatment
Immunotherapeutic and targeted approaches might make mesothelioma more responsive to chemotherapy. Malignant pleural mesothelioma is an aggressive disease. Asbestos exposure…
Bevacizumab: An Immune Therapy in Mesothelioma Treatment
Bevacizumab, an immune therapy, enhances the immune system to target cancer cells. Historically, chemotherapy drugs were considered the standard treatment.…
Celiac Disease May Be a Little-Known Complication of Mesothelioma Immunotherapy
A new French case report shines a spotlight on a little-known potential complication of mesothelioma immunotherapy: celiac disease. Celiac disease…
“Remodeling” Mesothelioma Cells May Improve Responsiveness to Immunotherapy
Italian researchers are experimenting with the idea of remodeling mesothelioma cells from the inside out to improve their responsiveness to…
Expert Says Malignant Mesothelioma Research ‘Turned a Corner’ in 2021
An internationally-known mesothelioma specialist says 2021 has been one of the best years yet for malignant mesothelioma research, giving patients…
Chemotherapy Still Good First-Line Option for Unresectable Epithelioid Mesothelioma
A top mesothelioma expert says chemotherapy may still be the best first-line treatment for unresectable epithelioid mesothelioma, even though immunotherapy…
Europe | Genetics | Immunotherapy | International | Research | Treatments
New CAR-T Cell Therapy for Mesothelioma Circumvents Immune Suppression
A new cancer treatment based on CAR-T cell therapy may have found a way to undermine a key protective mechanism…
Immunotherapy Drug Durvalumab Shines in Most Recent Mesothelioma Trial
Another new study confirms what Johns Hopkins researchers have been banking on – that the immunotherapy drug durvalumab can make…
Drug Reation May Predict Mesothelioma Immunotherapy Results
Patients who have more serious reactions to the drug nivolumab tend to have better mesothelioma immunotherapy results than those who…